# Item 9 Labs Corp. (INLB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/INLB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 11.55M | $ -10.08M | $ 423.2K | $ 34.30M | $ 52.65M |
| 2022 | $ 22.98M | $ -34.67M | $ -7.03M | $ 32.59M | $ 60.37M |
| 2021 | $ 29.82M | $ -15.66M | $ -10.23M | $ 21.93M | $ 84.46M |
| 2020 | $ 12.27M | $ -14.52M | $ -4.66M | $ 6.96M | $ 13.20M |
| 2019 | $ 7.11M | $ -14.77M | $ -11.01M | $ 5.48M | $ 5.72M |
| 2018 | $ 2.78M | $ -1.39M | $ -3.01M | $ 0 | $ 2.56M |
| 2017 | $ 448.6K | $ -1.55M | $ -24.0K | $ 144.2K | $ -1.84M |
| 2016 | $ 316.0K | $ -3.88M | $ -374.0K | $ 386.9K | $ -2.17M |
| 2015 | $ 175.0K | $ -5.92M | $ -868.7K | $ 3.27M | $ -5.04M |
| 2014 | $ 370.3K | $ -23.79M | $ -1.06M | $ 1.78M | $ -2.94M |
| 2013 | $ 389.0K | $ -5.84M | $ -982.5K | $ 496.0K | $ -3.75M |
| 2012 | $ 1.37M | $ -1.60M | $ -1.24M | $ 1.30M | $ -2.38M |
| 2011 | $ 0 | $ -2.05M | $ -59.3K | $ 1.35M | $ -5.0K |
| 2010 | $ 0 | $ -32.7K | $ -18.1K | $ 0 | $ -22.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.65 |
| Liabilities / Eq | 1.13 |
| Current Ratio | 0.06 |

## Other views

- [Metrics](https://sponda.capital/en/INLB.md)
- [Charts](https://sponda.capital/en/INLB/charts.md)
- [Compare](https://sponda.capital/en/INLB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.